Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


V A Shiva Ayyadurai

V A Shiva Ayyadurai

CytoSolve Inc., USA

Title: The future of food: Evidence-based science for the natural products Industry


Biography: V A Shiva Ayyadurai


The natural product industry is one of fastest growing industry with revenue of over size of $187B. However it is constantly under attack and is having to defend itself. One of the weaknesses for the industry is not always having the data that a products are safe, efficacious and work for the particular ailment, compared to the pharmaceutical industry. The fact that the pharmaceutical industry has to concern itself with only single synthetic molecules as opposed to the multi-molecule products in the natural product industry adds to the complexity of providing safe and efficacious products to the consumer by the natural product industry. Health and wellbeing is based on combinations of multiple molecules, which is what food is, and tuning that combination for a particular systemic effect. CytoSolve, a computational systems biology collaboratory, is a proven, revolutionary technology developed at M.I.T. that can help the natural supplement industry by discovering formulations that are efficacious and safe, building real trust in customers based on science, defending the industry from attacks, and proactively protecting and strengthening the industry by discovery. CytoSolve uses a holistic, systems-based approach towards understanding the
underlying biology and come up with single or multi-ingredient solutions for a physiological condition or a disease. Based on proprietary in silico technology and a feedback systems design that mines existing peer-reviewed literature for validated molecular mechanisms, while reusing scientific data from wet lab and clinical trials, CytoSolve offers a revolutionary and proven information-centric platform that delivers accurate quantitative mechanistic models, for predicting complex molecular phenomena. These models enable rapid in silico testing for the development of single and multi-combination compounds for drugs, nutritional supplements, and medical foods, by optimizing in vitro and in vivo testing. Leading pharmaceutical and functional food companies as well as major universities, foundations and government agencies, are now using this revolutionary approach to accelerate development. This talk that will provide an introduction to a disruptive platform that will likely revolutionize understanding of natural supplements, food nutrition and food safety in the 21st century.